R. Nieman

Factors influencing colonisation and antibiotic-resistance patterns of gram-negative bacteria in hospital patients.

P. Hardy, M. Jett, M. Pollack, 1972, Lancet.

Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study

C. Brambilla, J. Edelson, G. Schultze-Werninghaus, 2001, The Lancet.

Co-trimoxazole versus dapsone-pyrimethamine for prevention of Pneumocystis carinii pneumonia

R. Nieman, RichardJ. Coker, M. Mcbride, 1992, The Lancet.

Diagnosis of Kikuchi's disease

R. Nieman, 1990, The Lancet.

Ariflo (SB 207499), a second generation phosphodiesterase 4 inhibitor for the treatment of asthma and COPD: from concept to clinic.

S. Christensen, R. Nieman, D. Underwood, 1999, Pulmonary pharmacology & therapeutics.